Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF FINANCIAL OFFICER

PRESIDENT AND COO

SVP, GLOBAL CONTROLLER

CHIEF SCIENTIFIC OFFICER

CHIEF EXECUTIVE OFFICER

CHIEF DEVELOPMENT OFFICER

CHIEF OPERATING OFFICER

HEAD OF RESEARCH & DEVELOPMENT

PRESIDENT AND CEO

SVP, Global Controller

Head of Research & Development

Chief Development Officer

Chief Operating Officer

Chief Financial Officer

President and CEO

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of primary sclerosing cholangitis and primary biliary cholangitis in adults. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilita...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-27	Premium	bought	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-03-25	Premium	sold	Premium	Premium	Premium	PRESIDENT AND COO
2024-03-18	Premium	bought	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-02-02	Premium	sold	Premium	Premium	Premium	SVP, GLOBAL CONTROLLER
2024-02-02	Premium	sold	Premium	Premium	Premium	PRESIDENT AND COO
2024-02-02	Premium	sold	Premium	Premium	Premium	CHIEF SCIENTIFIC OFFICER
2024-02-02	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-02-02	Premium	sold	Premium	Premium	Premium	CHIEF DEVELOPMENT OFFICER
2024-01-31	Premium	acquired	Premium	Premium	Premium	SVP, GLOBAL CONTROLLER
2024-01-08	Premium	sold	Premium	Premium	Premium	SVP, GLOBAL CONTROLLER
2024-01-08	Premium	sold	Premium	Premium	Premium	CHIEF OPERATING OFFICER
2024-01-08	Premium	sold	Premium	Premium	Premium	HEAD OF RESEARCH & DEVELOPMENT
2024-01-08	Premium	sold	Premium	Premium	Premium	PRESIDENT AND CEO
2024-01-08	Premium	sold	Premium	Premium	Premium	CHIEF DEVELOPMENT OFFICER
2024-01-06	Premium	acquired	Premium	Premium	Premium	SVP, GLOBAL CONTROLLER
2023-12-05	Premium	acquired	Premium	Premium	Premium	SVP, Global Controller
2023-12-05	Premium	sold	Premium	Premium	Premium	SVP, Global Controller
2023-11-10	Premium	acquired	Premium	Premium	Premium	Head of Research & Development
2023-11-10	Premium	acquired	Premium	Premium	Premium	Chief Development Officer
2023-11-10	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-11-09	Premium	bought	Premium	Premium	Premium	-
2023-09-14	Premium	acquired	Premium	Premium	Premium	-
2023-09-14	Premium	sold	Premium	Premium	Premium	-
2023-09-13	Premium	acquired	Premium	Premium	Premium	-
2023-09-13	Premium	sold	Premium	Premium	Premium	-

MIRM - Mirum Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for MIRM